Companies: 10,795·Total market cap: $144.5T
Evotec SE

Evotec SE

EVONASDAQHealthcare● Active
$2.80
+$0.00(+0.00%)
Market Cap$994526590
P/E Ratio
52W High$4.44
52W Low$2.31

Evotec SE(EVO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · EVO · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.76B$0.80B$0.78B$0.75B$0.62B
Cost of Revenue$0.69B$0.68B$0.61B$0.58B$0.47B
Gross Profit$0.06B$0.11B$0.18B$0.17B$0.15B
Gross Margin %(computed)8.27%14.41%22.40%23.16%24.52%
Operating Expenses
R&D Expenses$0.07B$0.05B$0.07B$0.08B$0.07B
G&A Expenses$0.00B$0.17B$0.15B$0.14B$0.10B
Total Operating Expenses$0.20B$0.26B$0.22B$0.15B$0.11B
Operating Income($0.14B)($0.14B)($0.05B)$0.02B$0.04B
Operating Margin %(computed)-17.87%-17.88%-6.08%2.77%6.63%
Interest Income$0.00B$0.00B$0.01B$0.01B$0.00B
Interest Expense$0.01B$0.01B$0.01B$0.01B$0.01B
Income Before Tax($0.12B)($0.19B)($0.08B)($0.15B)$0.24B
Income Tax Expense($0.02B)$0.00B$0.00B$0.02B$0.02B
Net Income($0.10B)($0.20B)($0.08B)($0.18B)$0.22B
Net Margin %(computed)-13.13%-24.60%-10.74%-23.38%34.87%
Per Share & EBITDA
EPS (Basic)$-0.28$-0.56$-0.23$-0.49$0.65
Wtd Avg Shares0.36B0.35B0.35B0.35B0.33B
EBITDA($0.04B)($0.08B)$0.02B($0.06B)$0.32B
EBITDA Margin %(computed)-5.25%-10.12%3.09%-7.67%51.23%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · EUR · B

深入了解Evotec SE

关于Evotec SE(EVO)损益表

Evotec SE(EVO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,EVO实现营收$0.76B,毛利润$0.06B(毛利率8.27%),净利润($0.10B)(净利率-13.13%)。

常见问题

EVO · 4 问

Evotec SE(EVO)2025财年营收为$0.76B,同比down5.0%。

EVO revenueEVO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08